Max Planck pioneers push boundaries in stem cell biology with the humble flatworm
Discover how researchers are harnessing novel slide-scanning technology to improve the understanding of regenerative biology
Discover how researchers are harnessing novel slide-scanning technology to improve the understanding of regenerative biology
Watch this on-demand webinar to learn about an alternative assay that aims to identify virus-neutralizing antibodies in as little as five hours
Watch this on-demand webinar to learn how NMR spectroscopy is a unique tool for the description of cellular processes and characterizing metal-binding protein structure
COVID-19 has led to a reversal of the downward trend in opioid misuse globally — watch this on-demand webinar to explore the crisis in depth
Watch this on-demand webinar to discover how Brillouin microscopy and Raman spectroscopy can revolutionize your biophysical and biochemical analyses
This aims to improve hygiene in public transportation and a reduction in transmission of infections of various origins
Subsidized technology available as global bodies call for sequencing to confirm COVID-19 mutations
LSM 980 NLO confocal microscope with GRIN lenses in combination with Airyscan 2 to be used in deep brain functional neuroscience research
These findings are crucial as rapidly spreading variants of SARS-CoV-2 have been reported in various countries
The novel self-labelling mammalian display method identifies antibodies against membrane proteins in their native configuration
Explore the advantages and applications of direct molecular testing for the diagnosis of bacterial and fungal pathogens
Explore topics from single-cell RNA sequencing sample preparation and precise weighing processes to COVID-19 serology testing and pediatric diagnostics
The exploratory research project aims to develop novel protein expression systems via cell reprogramming
Diagnostics business focused on producing customized long RNAs and DNAs for in vitro diagnostics, complements existing Merck portfolio
Used for MALDI Biotyper identification directly from positive blood cultures with short time-to-result of less than 30 minutes
Dr. Komal Kumar Javarappa shares insights from the multidisciplinary forefront of immuno-oncology, where translational biologists race against time to optimize new cancer therapies